» Articles » PMID: 22213019

Is Oxidative Stress, a Link Between Nephrolithiasis and Obesity, Hypertension, Diabetes, Chronic Kidney Disease, Metabolic Syndrome?

Overview
Journal Urol Res
Specialty Urology
Date 2012 Jan 4
PMID 22213019
Citations 83
Authors
Affiliations
Soon will be listed here.
Abstract

Epidemiological studies have provided the evidence for association between nephrolithiasis and a number of cardiovascular diseases including hypertension, diabetes, chronic kidney disease, metabolic syndrome. Many of the co-morbidities may not only lead to stone disease but also be triggered by it. Nephrolithiasis is a risk factor for development of hypertension and have higher prevalence of diabetes mellitus and some hypertensive and diabetic patients are at greater risk for stone formation. An analysis of the association between stone disease and other simultaneously appearing disorders, as well as factors involved in their pathogenesis, may provide an insight into stone formation and improved therapies for stone recurrence and prevention. It is our hypothesis that association between stone formation and development of co-morbidities is a result of certain common pathological features. Review of the recent literature indicates that production of reactive oxygen species (ROS) and development of oxidative stress (OS) may be such a common pathway. OS is a common feature of all cardiovascular diseases (CVD) including hypertension, diabetes mellitus, atherosclerosis and myocardial infarct. There is increasing evidence that ROS are also produced during idiopathic calcium oxalate (CaOx) nephrolithiasis. Both tissue culture and animal model studies demonstrate that ROS are produced during interaction between CaOx/calcium phosphate (CaP) crystals and renal epithelial cells. Clinical studies have also provided evidence for the development of oxidative stress in the kidneys of stone forming patients. Renal disorders which lead to OS appear to be a continuum. Stress produced by one disorder may trigger the other under the right circumstances.

Citing Articles

Advances in the mechanism of urinary proteins in calcium oxalate kidney stone formation.

Shi M, Su X, Xiang H, Song Q, Yang S Urolithiasis. 2025; 53(1):27.

PMID: 39932538 DOI: 10.1007/s00240-025-01703-6.


Therapeutic potential of seaweeds and their biofabricated nanoparticles in treating urolithiasis: A review.

Raj C T D, Palaninathan V, Kandaswamy S, Kumar V, James R Heliyon. 2025; 11(1):e41132.

PMID: 39802010 PMC: 11720914. DOI: 10.1016/j.heliyon.2024.e41132.


Association Between Dietary Selenium Intake and Kidney Stones Disease Among Patients with Metabolic Syndrome: A Cross-Sectional Study from the NHANES Database.

Zhang D, Han W, Yang Y, Tong X, Xiao J J Multidiscip Healthc. 2025; 17:6255-6264.

PMID: 39759084 PMC: 11699850. DOI: 10.2147/JMDH.S496819.


Trends in kidney stone prevalence among U.S. adults A concerning contemporary gender analysis from the NHANES database.

Chen K, Meskawi M, Miller L, Bhattacharyya S, Tailly T, Chew B Can Urol Assoc J. 2024; 19(2):58-60.

PMID: 39418488 PMC: 11819852. DOI: 10.5489/cuaj.8935.


ROS Chronicles in HIV Infection: Genesis of Oxidative Stress, Associated Pathologies, and Therapeutic Strategies.

Harshithkumar R, Shah P, Jadaun P, Mukherjee A Curr Issues Mol Biol. 2024; 46(8):8852-8873.

PMID: 39194740 PMC: 11352872. DOI: 10.3390/cimb46080523.


References
1.
Stefanadi E, Tousoulis D, Androulakis E, Papageorgiou N, Charakida M, Siasos G . Inflammatory markers in essential hypertension: potential clinical implications. Curr Vasc Pharmacol. 2009; 8(4):509-16. DOI: 10.2174/157016110791330870. View

2.
Khan S, Glenton P, Byer K . Modeling of hyperoxaluric calcium oxalate nephrolithiasis: experimental induction of hyperoxaluria by hydroxy-L-proline. Kidney Int. 2006; 70(5):914-23. DOI: 10.1038/sj.ki.5001699. View

3.
Weller R, Nester B, Cooke S . Calcification in the human renal papilla: an electron-microscope study. J Pathol. 1972; 107(3):211-6. DOI: 10.1002/path.1711070308. View

4.
Okonogi H, Nishimura M, Utsunomiya Y, Hamaguchi K, Tsuchida H, Miura Y . Urinary type IV collagen excretion reflects renal morphological alterations and type IV collagen expression in patients with type 2 diabetes mellitus. Clin Nephrol. 2001; 55(5):357-64. View

5.
Borghi L, Meschi T, Guerra A, Briganti A, Schianchi T, Allegri F . Essential arterial hypertension and stone disease. Kidney Int. 1999; 55(6):2397-406. DOI: 10.1046/j.1523-1755.1999.00483.x. View